Connect with Gradiant Bioconvergence at Hi Korea 2024
Exhibiting at Hi Korea 2..Hi Korea 2024
Hall ..Hall A, COEX, Seoul, Korea
27 Aug - 29 Aug, 2024
F41F41
Gradiant B...
Add to Leads
Company Type
Contract Service
Biotech
Product Categories
Organoids
Drug Evaluation
AI Analysis
Product Items
Patient-Derived Organoids (PDO)
Organoid Culture
Drug Evaluation Platforms
AI-Based Analysis Algorithms
Company Overview
Gradiant Bioconvergence specializes in the development and application of organoid culture technology, providing comprehensive contract research services. The company focuses on patient-derived organoid (PDO) banking, drug evaluation platforms, and AI-based analysis algorithms to support innovative drug discovery and development.
Videos & Images
Exhibitor Contact
Address
4th Fl, 558, Songpa-daero, Songpa-gu, Seoul, Republic of Korea
Gradiant Bioconvergence specializes in the development and application of organoid culture technology, providing comprehensive contract research services. The company focuses on patient-derived organoid (PDO) banking, drug evaluation platforms, and AI-based analysis algorithms to support innovative drug discovery and development.
